About the Authors

Kevin Outterson

mko@bu.edu

Affiliations Boston University School of Law, Boston, Massachusetts, United States of America, Chatham House Centre for Global Health Security, London, United Kingdom, DRIVE-AB, Innovative Medicines Initiative, Geneva, Switzerland

Unni Gopinathan

Affiliations Oslo University Hospital, Oslo, Norway, Norwegian Institute of Public Health, Oslo, Norway

Charles Clift

Affiliations Chatham House Centre for Global Health Security, London, United Kingdom, DRIVE-AB, Innovative Medicines Initiative, Geneva, Switzerland

Anthony D. So

Affiliations Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America, ReAct - Action on Antibiotic Resistance, Uppsala, Sweden

Chantal M. Morel

Affiliations DRIVE-AB, Innovative Medicines Initiative, Geneva, Switzerland, London School of Economics, London, United Kingdom

John-Arne Røttingen

Affiliations Chatham House Centre for Global Health Security, London, United Kingdom, DRIVE-AB, Innovative Medicines Initiative, Geneva, Switzerland, Norwegian Institute of Public Health, Oslo, Norway, University of Oslo, Oslo, Norway, Harvard School of Public Health, Boston, Massachusetts, United States of America

Competing Interests

AS's work on antibiotic resistance is supported both by a Swedish Sida grant for ReAct—Action on Antibiotic Resistance and as a recipient of the Robert Wood Johnson Investigator Award in Health Policy Research. CC is Chair of the Governing Board of the Medicines Patent Pool. The remaining authors have declared that no competing interests exist.

Author Contributions

Wrote the first draft of the manuscript: UG. Contributed to the writing of the manuscript: KO UG CC AS CMM JAR. Agree with the manuscript’s results and conclusions: KO UG CC AS CMM JAR. All authors have read, and confirm that they meet, ICMJE criteria for authorship.